Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chan Kwon

Showing results (951-960 of 1,162) with videos related to

Pageof 117
Sort By:
Scientific Reports|November 4, 2014
Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: sequential delivery of doxorubicin and Bcl-2 siRNAHong Yeol Yoon, Sejin Son, So Jin Lee, et al.
Nano Letters|September 20, 2016
Long-Circulating Au-TiO<sub>2</sub> Nanocomposite as a Sonosensitizer for ROS-Mediated Eradication of CancerV G Deepagan, Dong Gil You, Wooram Um, et al.
American Journal of Hematology|November 26, 2002
Urokinase could increase the yield of progenitor cells during red cell depletion in elapsed and anticoagulated cord bloodYoung-Ho Lee, Jin-Yeong Han, Su-Yeong Seo, et al.
The Korean Journal of Internal Medicine|February 19, 2020
Risk factors for primary lung cancer among never-smoking women in South Korea: a retrospective nationwide population-based cohort studyYoon Ho Ko, Seung Joon Kim, Wan-Seop Kim, et al.
Cancer Cytopathology|September 15, 2020
Impact of the COVID-19 pandemic on cytology practice: An international survey in the Asia-Pacific regionYeh-Han Wang, Andrey Bychkov, Indranil Chakrabarti, et al.
American Journal of Clinical Oncology|September 23, 2009
A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancerByung Geun Kim, Sung Yong Oh, Hyuk-Chan Kwon, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 14, 2010
Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drugBeom Suk Lee, Kyeongsoon Park, Sangjin Park, et al.
Theranostics|March 1, 2014
Cell labeling and tracking method without distorted signals by phagocytosis of macrophagesSun-Woong Kang, Sangmin Lee, Jin Hee Na, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 21, 2016
Predicting the in vivo accumulation of nanoparticles in tumor based on in vitro macrophage uptake and circulation in zebrafishHyeyoun Chang, Ji Young Yhee, Gun Hyuk Jang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2025
Validation of Diagnostic Utility of Washout CYFRA 21-1 in Lymph Node Metastasis of Thyroid CancerJeongmin Lee, Yuri Shin, Jeongun Kwak, et al.
Pageof 117

Showing results (951-960 of 1,162) with videos related to

Sort By:
Pageof 117
Scientific Reports|November 4, 2014
Glycol chitosan nanoparticles as specialized cancer therapeutic vehicles: sequential delivery of doxorubicin and Bcl-2 siRNAHong Yeol Yoon, Sejin Son, So Jin Lee, et al.
Nano Letters|September 20, 2016
Long-Circulating Au-TiO<sub>2</sub> Nanocomposite as a Sonosensitizer for ROS-Mediated Eradication of CancerV G Deepagan, Dong Gil You, Wooram Um, et al.
American Journal of Hematology|November 26, 2002
Urokinase could increase the yield of progenitor cells during red cell depletion in elapsed and anticoagulated cord bloodYoung-Ho Lee, Jin-Yeong Han, Su-Yeong Seo, et al.
The Korean Journal of Internal Medicine|February 19, 2020
Risk factors for primary lung cancer among never-smoking women in South Korea: a retrospective nationwide population-based cohort studyYoon Ho Ko, Seung Joon Kim, Wan-Seop Kim, et al.
Cancer Cytopathology|September 15, 2020
Impact of the COVID-19 pandemic on cytology practice: An international survey in the Asia-Pacific regionYeh-Han Wang, Andrey Bychkov, Indranil Chakrabarti, et al.
American Journal of Clinical Oncology|September 23, 2009
A phase II study of irinotecan with biweekly, low dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as first line therapy for patients with recurrent or metastatic gastric cancerByung Geun Kim, Sung Yong Oh, Hyuk-Chan Kwon, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 14, 2010
Tumor targeting efficiency of bare nanoparticles does not mean the efficacy of loaded anticancer drugs: importance of radionuclide imaging for optimization of highly selective tumor targeting polymeric nanoparticles with or without drugBeom Suk Lee, Kyeongsoon Park, Sangjin Park, et al.
Theranostics|March 1, 2014
Cell labeling and tracking method without distorted signals by phagocytosis of macrophagesSun-Woong Kang, Sangmin Lee, Jin Hee Na, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|July 21, 2016
Predicting the in vivo accumulation of nanoparticles in tumor based on in vitro macrophage uptake and circulation in zebrafishHyeyoun Chang, Ji Young Yhee, Gun Hyuk Jang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2025
Validation of Diagnostic Utility of Washout CYFRA 21-1 in Lymph Node Metastasis of Thyroid CancerJeongmin Lee, Yuri Shin, Jeongun Kwak, et al.
Pageof 117